Interference with ADAM17 inhibits proliferation of human cervical cancer cell line HeLa

doi:10.16352/j.issn.1001-6325.2022.02.005

Abstract

Abstract: Objective To investigate the effect of ADAM17 on proliferation of cervical cancer cells in vitro and its mechanism. Methods The specific shRNA against ADAM17 was transfected into HeLa cells. Western blot and RT-qPCR were used to examine the interference efficiency. The relative rates of proliferation were determined by CCK-8 assay. The migration and invasion were evaluated by scratch test and Transwell test.Western blot was used to detect the protein expression of PCNA, EGFR, p-EGFR, ERK and p-ERK in each group. Results The expression of ADAM17 mRNA and protein were decreased in HeLa cells transfected by sh-ADAM17(P＜0.05).ADAM17 had no effect on migration and invasion of cervical cancer cells,but ADAM17 interference significantly inhibited the proliferation of cervical cancer HeLa cells(P＜0.05). The expression of PCNA, p-EGFR and p-ERK protein was down-regulated(P＜0.05). Conclusions Interfering with ADAM17 can inhibit the proliferation of human cervical cancer cell line HeLa, which may be related to EGFR/ERK signaling pathway.

Key words: cervical cancer, a disintegrin and metalloproteinase 17, proliferation

CLC Number:

R737.33

ZHANG Chun-li, QI Jie-hua, HUAN Yu, WU Shou-le, CAI Xu-shan. Interference with ADAM17 inhibits proliferation of human cervical cancer cell line HeLa[J]. Basic & Clinical Medicine, 2022, 42(2): 255-259.

References

[1]Verma J, Monk BJ, Wolfson AH. New strategies for multimodality therapy in treating locally advanced cervix cancer[J]. Semin Radiat Oncol, 2016, 26: 344-348.
[2]Liu HB, Zhu Y, Yang QC, et al. Expression and clinical significance of Adam17 protein in esophageal squamous cell cancer[J]. Genet Mol Res, 2015, 14: 4391-4398.
[3]Li Y, Ren Z, Wang Y, et al. Adam17 promotes cell migration and invasion through the integrin β1 pathway in hepatocellular cancer[J]. Exp Cell Res, 2018, 370: 373-382.
[4]Saad M, Alhayyani S, Mcleod L, et al. Adam17 selectively activates the IL-6 trans-signaling/ERK MAPK axis in KRAS-addicted lung cancer[J]. EMBO Mol Med, 2019, 11: e9976. doi: 10.15252/emmm.201809976.
[5]Li W, Wang DG, Sun X, et al. Adam17 promotes lymph node metastasis in gastric cancer via activation of the Notch and Wnt signaling pathways[J]. Int J Mol Med, 2019, 43: 914-926.
[6]刘爽, 马荣, 贺云龙, 等. 宫颈鳞状细胞癌中ADAM17的表达及其临床意义[J].现代生物医学进展, 2016, 16:2868-2871.
[7]Eskander RN, Tewari KS. Chemotherapy in the treatment of metastatic, persistent, and recurrent cervical cancer[J]. Curr Opin Obstet Gynecol, 2014, 26: 314-321.
[8]Chantalat E, Vidal F, Leguevaque P, et al. Cervical cancer with paraaortic involvement: do patients truly benefit from tailored chemoradiation therapy? A retrospective study on 8 French centers[J]. Eur J Obstet Gynecol Reprod Biol, 2015, 193: 118-122.
[9]李晨浩, 魏艳杰, 田炜, 等. ADAM17在甲状腺乳头状癌中表达及意义[J]. 基础医学与临床, 2016, 36:393-395.
[10]Kim TW, Ryu HH, Li SY, et al. PDIA6 regulation of Adam17 shedding activity and EGFR-mediated migration and invasion of glioblastoma cells[J]. J Neuro Surg, 2017, 126: 1829-1838.
[11]Meng X, Hu B, Hossain MM, et al. ADAM17-siRNA inhibits MCF-7 breast cancer through EGFR-PI3K-AKT activation[J]. Int J Oncol, 2016, 49: 682-690.
[12]Hu B, Meng XC, Zhang Y, et al. Short hairpin RNA-mediated gene silencing of Adam17 inhibits the growth of breast cancer MCF-7 cells in vitro and in vivo and its mechanism of action[J]. Oncol Rep, 2018, 39: 1640-1648.

[1]	XIAO Yanhong, JIANG Mingdong, LIN Yeyuan, RAN Can, LIANG Bo. Scutellarin inhibits proliferation and migration of human prostate cancer cell line PC-3 [J]. Basic & Clinical Medicine, 2024, 44(9): 1229-1235.
[2]	YAO Anjun, CHEN Lingzi, JIN Huixian. Docosahexaenoic acid inhibits proliferation of human colon cancer cell line HT-29 [J]. Basic & Clinical Medicine, 2024, 44(8): 1107-1112.
[3]	ZHENG Hong, CHEN Xiaoxia, HAN Lizhou, CHEN Miao, HUANGFU Juan. Decrease of lncRNA-RMRP expression inhibits proliferation and invasion of human lung cancer cell line A549 [J]. Basic & Clinical Medicine, 2024, 44(7): 974-978.
[4]	CAO Qingwen, QI Lin, YU Bo, TIAN Chenchen, YUAN Haining, WANG Yue. Salidroside promotes proliferation and migration of human vascular endothelial cell line EA.hy926 [J]. Basic & Clinical Medicine, 2024, 44(7): 925-930.
[5]	ZHANG Pengju, LI Jie, ZHANG Mengdi, SUN Shaoke, XU Yinzhe. KAT8 promotes the proliferation of colorectal cancer cell lines by enhancing METTL3 expression [J]. Basic & Clinical Medicine, 2024, 44(7): 931-939.
[6]	GAO Yinjie, TONG Anli. Mechanisms of cell death and proliferation of aldosterone-producing adenoma [J]. Basic & Clinical Medicine, 2024, 44(6): 758-762.
[7]	WANG Tingting, XIAO Ning, LIN Dianxin, DONG Haitao. Allicin inhibits the proliferation of oral cancer cells line CAL27 [J]. Basic & Clinical Medicine, 2024, 44(5): 673-676.
[8]	JIA Anna, GUO Jinxin, ZHANG Xuan, ZHAN Shijia, YU Yongbo, GUO Yongli, CHANG Yan. Regulation of TMEFF1 on proliferation of neuroblastoma cell lines [J]. Basic & Clinical Medicine, 2024, 44(5): 637-644.
[9]	LIANG Xiangcun, WEI Xiaoyu, LIANG Jian, WANG Qing, GENG Guang. Anlotinib inhibits proliferation and promotes apoptosis of human non-small cell lung cancer cell lines through miR-16-5p/PD-1 axis [J]. Basic & Clinical Medicine, 2024, 44(4): 503-512.
[10]	LU Kai, LU Jianju, GUO Wenli, HUANG Jianqi, LI Zhihua. lncRNA VIM-AS5 expression and its effect on proliferation and migration of human breast cancer cell lines [J]. Basic & Clinical Medicine, 2024, 44(4): 447-453.
[11]	YANG Kaifei, ZHU Jingge, ZHANG Yangyang, ZHAO Junguo, GAO Yuyue, HU Huanhuan, JI Guojie. Effect of sorafenib induced apoptosis and autophagy on drug resistance in HeLa cells [J]. Basic & Clinical Medicine, 2024, 44(4): 467-473.
[12]	GUO Hongjiang, XU Yeting, ZHANG Diya, QIU Jiaxing, WANG Yucheng, JU Rui, GUO Lei. Effect of carboxyamidotriazole-orotate on proliferation and fatty acid anabolism of human pancreatic cancer cell lines [J]. Basic & Clinical Medicine, 2024, 44(4): 440-446.
[13]	LI Na, LI Tao, YANG Dongli, YAO Yuan. Honokiol inhibits the proliferation of human adipose-derived mesenchymal stem cells [J]. Basic & Clinical Medicine, 2024, 44(4): 483-488.
[14]	ZHANG Jing, YANG Zigeng, CAI Wenqin, CAO Weiwei, WEI Hongmei, XUE Xixi, WU Bin. Inhibition of prohibitin 2 enhances the sensitivity of non-small cell lung cancer cell line A549 to erlotinib [J]. Basic & Clinical Medicine, 2024, 44(3): 325-332.
[15]	AN Qi, QI Guangzhao, HAN Chao. Aucubin inhibits the proliferation of human hepatocellular carcinoma cells line HepG2 [J]. Basic & Clinical Medicine, 2024, 44(3): 333-338.